Abiopharma

Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

HCA Healthcare Announces $1.5 Million HCA Healthcare Foundation Grant to Support March of Dimes Low Dose, Big Benefits™ Campaign

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Vistagen to Participate in Stifel Healthcare Conference 2025